American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

LIPELLA PHARMACEUTICALS INC. (LIPO)

$0.00 +0.00% OTC: LIPO · 15-min delayed

PITTSBURGH, Pennsylvania
Public · OTC: LIPO

Visit website Follow

$536.4KRevenue · FY2024

-$5.0MNet income

LIPOOTC

About LIPELLA PHARMACEUTICALS INC.

LIPELLA PHARMS INC

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: LIPO
Headquarters: PITTSBURGH, Pennsylvania
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: LIPO OTC
SEC CIK: 1347242
SIC: 2834 Pharmaceutical Preparations

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Lipella Pharmaceuticals Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/lipella-pharmaceuticals-inc/"><img src="https://americancompanies.com/badge/lipella-pharmaceuticals-inc.svg" alt="Lipella Pharmaceuticals Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow LIPELLA PHARMACEUTICALS INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2024: $536.4K
Net income: -$5.0M
Total assets: $2.7M

Source: SEC EDGAR · updated Jun 8, 2026

OTC: LIPO

$0.00 +0.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.00 $0.64

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Lipella Pharmaceuticals Inc. (LIPO) Stock Price

Reported a net loss of $5.0M in FY2024.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review LIPELLA PHARMACEUTICALS INC..

Write a review

Newsroom

News about LIPELLA PHARMACEUTICALS INC.

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus GlobeNewswire Inc. · 2025-04-08 · positive Spartan Capital Securities, LLC Announces Key February Transactions GlobeNewswire Inc. · 2025-03-07 · positive Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus GlobeNewswire Inc. · 2025-02-11 · positive Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus GlobeNewswire Inc. · 2025-02-06 · positive Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement GlobeNewswire Inc. · 2025-01-10 · positive Spartan Capital Securities, LLC Caps Off a Remarkable Year with Key December Transactions GlobeNewswire Inc. · 2024-12-31 · positive

News & sentiment via Polygon.io

FAQ

Lipella Pharmaceuticals Inc.: frequently asked questions

Is Lipella Pharmaceuticals Inc. an American company?

Lipella Pharmaceuticals Inc. is a US-based company headquartered in Pittsburgh, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Lipella Pharmaceuticals Inc. headquartered?

Lipella Pharmaceuticals Inc. is headquartered in Pittsburgh, Pennsylvania, United States.

Is Lipella Pharmaceuticals Inc. publicly traded?

Yes — Lipella Pharmaceuticals Inc. is a publicly traded company. Its stock trades under the ticker symbol LIPO on the OTC.

What does Lipella Pharmaceuticals Inc. do?

Lipella Pharmaceuticals Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore